Impact of Factor V Leiden Mutation on Duration of Anticoagulation after a Single Thromboembolic Event

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Thromb Haemost 1997; 77(02): 405
DOI: 10.1055/s-0038-1655978

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Claudia Rintelen

Medical Clinic I, Division of Haematology and Haemostaseology, Vienna, Austria
Ingrid Pabinger

Medical Clinic I, Division of Haematology and Haemostaseology, Vienna, Austria
Klaus Lechner

Medical Clinic I, Division of Haematology and Haemostaseology, Vienna, Austria
Christine Mann-halter

¹Department of Laboratory Medicine, Division of Molecular Biology, University Hospital Vienna, Vienna, Austria

Received 13. September 1996

Accepted 13. September 1996

Publikationsdatum:
10. Juli 2018 (online)

References
1 Ridker PM. Leiden and recurrent venous thromboembolism. Thromb Haemos 1996; 76: 815-816

Reference Link Ris
PubMed Suche in Google Scholar
2 Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost 1996; 75: 229-232

Reference Link Ris
Thieme Connect PubMed Suche in Google Scholar
3 Ridker PM, Miletich J, Goldhaber SZ, Stampfer MJ, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboemblism. Circulation 1995; 92: 2800-2802

Reference Link Ris
Crossref PubMed Suche in Google Scholar
4 Eichinger S, Pabinger I, Stüpflen A, Hirschl L, Bialonczyk C, Forberg E, Schneider B, Rintelen C, Lechner K, Kyrle PA. The risk of recurrent venous thrombosis after discontinuation of oral anticoagulants in patients without and with factor V Leiden and the predictive value of a molecular marker of thrombosis. Blood 1995; 86 (Suppl. 01) 615a

Reference Link Ris
PubMed Suche in Google Scholar